15-73556299-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001042367.2(REC114):c.547-3C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00315 in 1,612,024 control chromosomes in the GnomAD database, including 146 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001042367.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
REC114 | NM_001042367.2 | c.547-3C>T | splice_region_variant, intron_variant | ENST00000331090.11 | NP_001035826.1 | |||
REC114 | NM_001348772.2 | c.463-3C>T | splice_region_variant, intron_variant | NP_001335701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
REC114 | ENST00000331090.11 | c.547-3C>T | splice_region_variant, intron_variant | 1 | NM_001042367.2 | ENSP00000328423.6 | ||||
REC114 | ENST00000560581.1 | c.463-3C>T | splice_region_variant, intron_variant | 2 | ENSP00000452908.1 |
Frequencies
GnomAD3 genomes AF: 0.0166 AC: 2527AN: 152100Hom.: 94 Cov.: 32
GnomAD3 exomes AF: 0.00429 AC: 1061AN: 247228Hom.: 25 AF XY: 0.00320 AC XY: 429AN XY: 134074
GnomAD4 exome AF: 0.00175 AC: 2551AN: 1459806Hom.: 51 Cov.: 30 AF XY: 0.00158 AC XY: 1148AN XY: 726156
GnomAD4 genome AF: 0.0166 AC: 2528AN: 152218Hom.: 95 Cov.: 32 AF XY: 0.0158 AC XY: 1176AN XY: 74416
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
REC114-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at